SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 13th, 2025 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledNovember 13th, 2025 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 29, 2025, between Guided Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 13th, 2025 • PS International Group Ltd. • Arrangement of transportation of freight & cargo • New York
Contract Type FiledNovember 13th, 2025 Company Industry JurisdictionTHIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of November 7, 2025, between PS International Group Ltd., an exempted company with limited liability incorporated under the laws of Cayman Islands (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 13th, 2025 • Blaize Holdings, Inc. • Semiconductors & related devices • New York
Contract Type FiledNovember 13th, 2025 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 10, 2025, between Blaize Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 13th, 2025 • Clearmind Medicine Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 13th, 2025 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 13, 2025, between Clearmind Medicine Inc., a British Columbia corporation (the “Company”), and each purchaser identified on the signature pages hereto (including their respective successors and assigns, each a “Purchaser” and collectively, the “Purchasers”).